Description
An active metabolite of E-64d; inhibits cathepsin B, cathepsin H, and papain; reduces the autocatalytic activity of the FMDV leader protease from 0.1-1 mg/ml; reduces infection of HEK293T cells by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein
Formal name: (2S,3S)-3[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-oxiranecarboxylic acid
Synonyms: Loxistatin Acid|NSC 694279
Molecular weight: 314.4
CAS: 76684-89-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases||Research Area|Cell Biology|Proteolysis|Lysosomal Proteases||Research Area|Immunology & Inflammation|Pulmonary Diseases|SARS||Research Area|Infectious Disease|Viral Diseases|Coronaviruses